J&J Medical Connect
Oncology
Oncology

Characteristics and Outcomes of Non-Transplanted Newly Diagnosed Multiple Myeloma Patients Treated With Daratumumab, Bortezomib, Lenalidomide, Dexamethasone (DVRd) With Once-Weekly Bortezomib Dosing